Lawrence Fong

Lawrence Fong

UNVERIFIED PROFILE

Are you Lawrence Fong?   Register this Author

Register author
Lawrence Fong

Lawrence Fong

Publications by authors named "Lawrence Fong"

Are you Lawrence Fong?   Register this Author

94Publications

2104Reads

8Profile Views

Segmenting Chinese Gamblers Based on Gambling Forms: A Latent Class Analysis.

J Gambl Stud 2019 Jul 19. Epub 2019 Jul 19.

Faculty of Business Administration, University of Macau, Avenida da Universidade, Taipa, Macau SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10899-019-09877-6DOI Listing
July 2019

Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory.

Cell 2019 Apr;177(2):414-427.e13

Department of Urology, University of California, San Francisco, San Francisco, CA 94143, USA; Eli and Edith Broad Institute for Regeneration Medicine, University of California, San Francisco, San Francisco, CA 94143, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2019.02.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499401PMC
April 2019

Itraconazole as a Noncastrating Treatment for Biochemically Recurrent Prostate Cancer: A Phase 2 Study.

Clin Genitourin Cancer 2019 Feb 24;17(1):e92-e96. Epub 2018 Sep 24.

University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2018.09.013DOI Listing
February 2019

Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade.

Immunity 2019 02 5;50(2):477-492.e8. Epub 2019 Feb 5.

Department of Hematology and Oncology, University of California, San Francisco, San Francisco, CA 94143, USA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2019.01.006DOI Listing
February 2019

Immunity in the Time of Metastases.

Immunity 2018 12;49(6):1002-1003

Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA 94143, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2018.12.008DOI Listing
December 2018

A Preclinical Assessment of Zr-atezolizumab Identifies a Requirement for Carrier Added Formulations Not Observed with Zr-C4.

Bioconjug Chem 2018 10 24;29(10):3476-3482. Epub 2018 Sep 24.

Department of Radiology and Biomedical Imaging , University of California, San Francisco , 505 Parnassus Avenue , San Francisco , California 94143 , United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.bioconjchem.8b00632DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430562PMC
October 2018

Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancer.

Oncoimmunology 2019 1;8(1):e1486953. Epub 2018 Oct 1.

Division of Hematology and Oncology, University of California, San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2018.1486953DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287789PMC
October 2018

Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.

Cell 2018 07 19;174(3):758-769.e9. Epub 2018 Jul 19.

Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, CA, USA; Division of Hematology and Oncology, Department of Medicine, UCSF, San Francisco, CA, USA; Department of Radiation Oncology, UCSF, San Francisco, CA, USA; Department of Urology, UCSF, San Francisco, CA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2018.06.039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425931PMC
July 2018

Clinical Variables Associated With Overall Survival in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Sipuleucel-T Immunotherapy.

Clin Genitourin Cancer 2018 06 27;16(3):184-190.e2. Epub 2017 Dec 27.

Division of Hematology/Oncology, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.12.004DOI Listing
June 2018

Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer.

J Clin Oncol 2018 06 28;36(16):1579-1587. Epub 2018 Mar 28.

David J. Vaughn, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Joaquim Bellmunt and Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA; Yves Fradet, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; Jae Lyun Lee, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; Lawrence Fong, University of California, San Francisco, San Francisco; David I. Quinn, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Miguel A. Climent, Fundación Instituto Valenciano de Oncología, Valencia, Spain; Daniel P. Petrylak, Smilow Cancer Hospital, Yale University, New Haven, CT; Andrea Necchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan; Cora N. Sternberg, San Camillo and Forlanini Hospitals, Rome, Italy; Winald Gerritsen, Radboud University Medical Center, Nijmegen; Ronald de Wit, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands; Howard Gurney, Westmead Hospital and Macquarie University, Sydney, New South Wales, Australia; Stephane Culine, Hôpital Saint-Louis, Paris, France; Yabing Mai, Haojie Li, and Rodolfo F. Perini, Merk & Co., Inc., Kenilworth, NJ; and Dean F. Bajorin, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.76.9562
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.76.9562DOI Listing
June 2018

Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity.

Cell Rep 2018 06;23(11):3262-3274

Diabetes Center, University of California, San Francisco, San Francisco, CA 94143, USA; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA; Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22111247183079
Publisher Site
http://dx.doi.org/10.1016/j.celrep.2018.05.050DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094952PMC
June 2018

Immunotherapy for Prostate Cancer: Where Do We Go From Here?-PART 1: Prostate Cancer Vaccines.

Oncology (Williston Park) 2018 03;32(3):112-20

View Article

Download full-text PDF

Source
March 2018

Shuffling the deck with CTLA-4 therapy: Deep sequencing of rearranged TCRB genes demonstrates T cell repertoire remodeling in cancer patients.

Oncoimmunology 2018 13;7(4):e956016. Epub 2018 Mar 13.

University of California, San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/21624011.2014.956016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889199PMC
March 2018

Single-cell RNA sequencing reveals gene expression signatures of breast cancer-associated endothelial cells.

Oncotarget 2018 Feb 29;9(13):10945-10961. Epub 2017 Dec 29.

Division of Neurointerventional Radiology, Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.23760DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834272PMC
February 2018

Imaging PD-L1 Expression with ImmunoPET.

Bioconjug Chem 2018 01 15;29(1):96-103. Epub 2017 Nov 15.

Department of Radiology and Biomedical Imaging, ‡Department of Medicine, §Helen Diller Family Comprehensive Cancer Center, ∥Department of Pharmaceutical Chemistry, and ⊥Department of Radiation Oncology, University of California, San Francisco , 505 Parnassus Avenue, San Francisco, California 94143, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.bioconjchem.7b00631DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773933PMC
January 2018

Combination central tolerance and peripheral checkpoint blockade unleashes antimelanoma immunity.

JCI Insight 2017 09 21;2(18). Epub 2017 Sep 21.

Department of Pediatrics and Microbiology/Immunology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/jci.insight.93265DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621898PMC
September 2017

Television During Meals in the First 4 Years of Life.

Clin Pediatr (Phila) 2017 Jun 16;56(7):659-666. Epub 2016 Nov 16.

1 University of California San Francisco, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0009922816678585DOI Listing
June 2017

Immune Toxicities Elicted by CTLA-4 Blockade in Cancer Patients Are Associated with Early Diversification of the T-cell Repertoire.

Cancer Res 2017 03 28;77(6):1322-1330. Epub 2016 Dec 28.

Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-16-2324DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398199PMC
March 2017

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.

N Engl J Med 2017 03 17;376(11):1015-1026. Epub 2017 Feb 17.

From Dana-Farber Cancer Institute, Boston (J.B., T.K.C.); Parc de Salut Mar, Hospital del Mar Medical Research Institute, Barcelona (J.B.), and Fundación Instituto Valenciano de Oncología, Valencia (M.A.C.) - both in Spain; Erasmus MC Cancer Institute, Rotterdam (R.W.), and Radboud University Medical Center, Nijmegen (W.G.) - both in the Netherlands; Abramson Cancer Center, University of Pennsylvania, Philadelphia (D.J.V.); Centre Hospitalier Universitaire de Québec-Université Laval, Quebec, QC, Canada (Y.F.); Asan Medical Center and University of Ulsan College of Medicine, Seoul, South Korea (J.-L.L.); the University of California, San Francisco, San Francisco (L.F.); Comprehensive Cancer Centers of Nevada, Las Vegas (N.J.V.); Smilow Cancer Hospital, Yale University, New Haven, CT (D.P.P.); Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (A.N.); Westmead Hospital and Macquarie University, Sydney (H.G.); the University of Southern California Norris Comprehensive Cancer Center and Hospital, Los Angeles (D.I.Q.); Hôpital Saint-Louis, Paris (S.C.); San Camillo and Forlanini Hospitals, Rome (C.N.S.); Merck, Kenilworth, NJ (Y.M., C.H.P., R.F.P.); and Memorial Sloan Kettering Cancer Center, New York (D.F.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1613683DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635424PMC
March 2017

3D: diversity, dynamics, differential testing - a proposed pipeline for analysis of next-generation sequencing T cell repertoire data.

BMC Bioinformatics 2017 Feb 27;18(1):129. Epub 2017 Feb 27.

Division of Hematology and Oncology, Department of Medicine, University of California, Room HSE301, UCSF Box 1270, 513 Parnassus Ave, San Francisco, CA, 94143-1270, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12859-017-1544-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5327583PMC
February 2017

Can Prostate Cancer Really Respond to Immunotherapy?

J Clin Oncol 2017 01 14;35(1):4-5. Epub 2016 Nov 14.

Won Kim and Lawrence Fong, University of California, San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.4791DOI Listing
January 2017

Systemic Immunity Is Required for Effective Cancer Immunotherapy.

Cell 2017 01 19;168(3):487-502.e15. Epub 2017 Jan 19.

Department of Pathology, Stanford University, Stanford, CA 94305, USA; Program in Immunology, Stanford University, Stanford, CA 94305, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2016.12.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312823PMC
January 2017

Immunotherapy in genitourinary malignancies.

Curr Opin Urol 2016 11;26(6):501-7

aHelen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California bGenitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://pdfs.journals.lww.com/co-urology/2016/11000/Immunothe
Web Search
http://dx.doi.org/10.1097/MOU.0000000000000331DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129842PMC
November 2016

Prospects for the use of ipilimumab in treating advanced prostate cancer.

Expert Opin Biol Ther 2016 25;16(3):421-32. Epub 2016 Jan 25.

a Division of Hematology and Oncology, UCSF Helen Diller Family Comprehensive Cancer Center , University of California, San Francisco , San Francisco , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2016.1136284DOI Listing
October 2016

Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future Directions.

Expert Rev Vaccines 2015 21;14(12):1529-41. Epub 2015 Oct 21.

a UCSF Helen Diller Family Comprehensive Cancer Center , University of California, San Francisco , San Francisco , CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14760584.2015.1099437DOI Listing
August 2016

Clonotypic Diversification of Intratumoral T Cells Following Sipuleucel-T Treatment in Prostate Cancer Subjects.

Cancer Res 2016 07 23;76(13):3711-8. Epub 2016 May 23.

Department of Medicine, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-3173DOI Listing
July 2016

Neoadjuvant therapy for localized prostate cancer: Examining mechanism of action and efficacy within the tumor.

Urol Oncol 2016 Apr 2;34(4):182-92. Epub 2014 Feb 2.

Division of Hematology/Oncology, University of California, San Francisco, CA; UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2013.12.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499005PMC
April 2016

Betting Decision Under Break-Streak Pattern: Evidence from Casino Gaming.

J Gambl Stud 2016 Mar;32(1):171-85

School of Hotel and Tourism Management, The Hong Kong Polytechnic University, 17 Science Museum Road, TST East, Kowloon, Hong Kong SAR, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10899-015-9550-1DOI Listing
March 2016

Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab.

Cancer Immunol Res 2015 Sep 12;3(9):1008-16. Epub 2015 May 12.

Division of Hematology/Oncology, University of California, San Francisco, California. UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561203PMC
September 2015

On the Verge: Immunotherapy for Colorectal Carcinoma.

J Natl Compr Canc Netw 2015 Aug;13(8):970-8

From the Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2015.0117DOI Listing
August 2015

Transglutaminase 4 as a prostate autoantigen in male subfertility.

Sci Transl Med 2015 Jun;7(292):292ra101

Department of Medicine (Solna), Karolinska University Hospital, Karolinska Institutet, Stockholm SE 171 76, Sweden. Department of Medical Sciences, Science for Life Laboratory, Uppsala University, Uppsala SE 751 85, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/scitranslmed.aaa9186DOI Listing
June 2015

Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer.

J Natl Cancer Inst 2014 Nov 24;106(11). Epub 2014 Sep 24.

University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA (LF, PC, VW, SC, JL, JS, EJS); Virginia Mason Medical Center, Seattle, WA (JC); Oregon Health & Science University, Portland, OR (CLA); University of Utah School of Medicine, Salt Lake City, UT (RAS); Dendreon Corporation, Seattle, WA (NAS, RBS, MWF).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju268DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241888PMC
November 2014

An examination of factors driving chinese gamblers' fallacy bias.

J Gambl Stud 2014 Sep;30(3):757-70

School of Hotel and Tourism Management, The Hong Kong Polytechnic University, 17 Science Museum Road, TST East, Kowloon, Hong Kong SAR, China,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10899-013-9390-9DOI Listing
September 2014

Enhancement of an anti-tumor immune response by transient blockade of central T cell tolerance.

J Exp Med 2014 May 21;211(5):761-8. Epub 2014 Apr 21.

Diabetes Center and 2 Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA 94143.

View Article

Download full-text PDF

Source
http://jem.rupress.org/content/211/5/761.full.pdf
Web Search
http://www.jem.org/lookup/doi/10.1084/jem.20131889
Publisher Site
http://dx.doi.org/10.1084/jem.20131889DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010907PMC
May 2014

The end of the beginning: circulating tumor cells as a biomarker in castration-resistant prostate cancer.

J Clin Oncol 2014 Apr 10;32(11):1104-6. Epub 2014 Mar 10.

Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.7307DOI Listing
April 2014

Beyond sipuleucel-T: immune approaches to treating prostate cancer.

Curr Treat Options Oncol 2014 Mar;15(1):115-26

University of California San Francisco, 513 Parnassus Ave., Box 0511, San Francisco, CA, 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-013-0267-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523381PMC
March 2014

Effects of RANKL-Targeted Therapy in Immunity and Cancer.

Front Oncol 2014 Jan 7;3:329. Epub 2014 Jan 7.

Division of Hematology and Oncology, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco , San Francisco, CA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2013.00329DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882875PMC
January 2014

Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resistant prostate cancer: results of a phase II study.

Urol Oncol 2012 Jul-Aug;30(4):408-14. Epub 2010 Oct 2.

Urologic Oncology Program, Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2010.06.014DOI Listing
November 2012

Diversity of antigen-specific responses induced in vivo with CTLA-4 blockade in prostate cancer patients.

J Immunol 2012 Oct 5;189(7):3759-66. Epub 2012 Sep 5.

Division of Hematology/Oncology, Department of Pathology, University of California, San Francisco, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1201529DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448828PMC
October 2012

Unmasking the immune recognition of prostate cancer with CTLA4 blockade.

Nat Rev Cancer 2012 03 1;12(4):289-97. Epub 2012 Mar 1.

Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco CA 94143-0511, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrc3223DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433280PMC
March 2012

A phase II study of insulin-like growth factor receptor inhibition with nordihydroguaiaretic acid in men with non-metastatic hormone-sensitive prostate cancer.

Oncol Rep 2012 Jan 4;27(1):3-9. Epub 2011 Oct 4.

Genitourinary Medical Oncology Program, Biostatistics and Computational Biology Core, Helen Diller Family Comprehensive Cancer Center, Department of Bioengineering and Therapeutic Sciences, Box 1711, 1600 Divisadaro Street, University of California, San Francisco, San Francisco, CA 94115-1711, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2011.1487DOI Listing
January 2012

A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma.

Cancer 2011 Sep 8;117(18):4194-200. Epub 2011 Mar 8.

Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143-1711, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25931DOI Listing
September 2011

Immunotherapy for prostate cancer: biology and therapeutic approaches.

J Clin Oncol 2011 Sep 8;29(27):3677-85. Epub 2011 Aug 8.

University of California, San Francisco, 513 Parnassus Ave, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.34.5025DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675707PMC
September 2011

Interplay between CD8α+ dendritic cells and monocytes in response to Listeria monocytogenes infection attenuates T cell responses.

PLoS One 2011 Apr 29;6(4):e19376. Epub 2011 Apr 29.

Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0019376PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3084837PMC
April 2011

Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients.

Cancer Res 2011 Jan 22;71(2):550-60. Epub 2010 Nov 22.

The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Department of Urology, UCSF-Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-1229DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022112PMC
January 2011

HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.

Cancer Immunol Immunother 2010 Jun 6;59(6):943-53. Epub 2010 Feb 6.

Department of Medicine, University of Wisconsin, Madison, WI 53792, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-010-0820-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038205PMC
June 2010

Developing immunotherapy as legitimate therapy for patients with prostate cancer.

J Clin Oncol 2010 Mar 25;28(7):1085-7. Epub 2010 Jan 25.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.26.3483DOI Listing
March 2010

Therapeutic vaccines for prostate cancer.

Curr Opin Mol Ther 2010 Feb;12(1):77-85

University of California San Francisco, 94143, USA.

View Article

Download full-text PDF

Source
February 2010

An aberrant prostate antigen-specific immune response causes prostatitis in mice and is associated with chronic prostatitis in humans.

J Clin Invest 2009 Jul;119(7):2031-41

Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, California 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1172/JCI38332DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701875PMC
July 2009

Anti-cytotoxic T-lymphocyte antigen-4 antibody: the first in an emerging class of immunomodulatory antibodies for cancer treatment.

J Clin Oncol 2008 Nov 6;26(32):5275-83. Epub 2008 Oct 6.

Department of Medicine, Division of Hematology/Oncology, University of California at San Francisco, San Francisco, CA 94143-0511, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.17.8954DOI Listing
November 2008

CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion.

Blood 2008 Aug 3;112(4):1175-83. Epub 2008 Jun 3.

Department of Microbiology and Immunology, Division of Hematology/Oncology, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-11-125435DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515138PMC
August 2008

SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade.

Proc Natl Acad Sci U S A 2008 Mar 26;105(9):3509-14. Epub 2008 Feb 26.

Departments of Urology and Medicine, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0712269105DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265147PMC
March 2008

Distinct CD8+ T cell repertoires primed with agonist and native peptides derived from a tumor-associated antigen.

J Immunol 2008 Feb;180(3):1526-34

Division of Hematology/Oncology, Department of Medicine, University of California-San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.180.3.1526DOI Listing
February 2008

Phase II study of ketoconazole plus granulocyte-macrophage colony-stimulating factor for prostate cancer: effect of extent of disease on outcome.

J Urol 2007 Dec 22;178(6):2372-6; discussion 2377. Epub 2007 Oct 22.

Urologic Oncology Program, University of California-San Francisco Comprehensive Cancer Center, University of California-San Francisco, San Francisco, California 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2007.08.011DOI Listing
December 2007

Immunotherapy for prostate cancer.

Curr Oncol Rep 2007 May;9(3):226-33

University of California, San Francisco, San Francisco, CA 94143-0511, USA.

View Article

Download full-text PDF

Source
May 2007

A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer.

Clin Cancer Res 2007 Mar;13(6):1810-5

UCSF Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-2318DOI Listing
March 2007

Spontaneous autoimmunity prevented by thymic expression of a single self-antigen.

J Exp Med 2006 Nov 20;203(12):2727-35. Epub 2006 Nov 20.

Diabetes Center and Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20061864DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118158PMC
November 2006

Immunotherapy for prostate cancer.

Curr Urol Rep 2006 May;7(3):239-46

University of California-San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
May 2006

CTLA-4 blockade: autoimmunity as treatment.

J Clin Oncol 2005 Dec 3;23(35):8926-8. Epub 2005 Oct 3.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.07.012DOI Listing
December 2005

Immunotherapy for prostate cancer.

Semin Oncol 2003 Oct;30(5):649-58

Department of Medicine, University of California, San Francisco, CA 94143, USA.

View Article

Download full-text PDF

Source
October 2003

Induction of immunity to tumor-associated antigens following dendritic cell vaccination of cancer patients.

Clin Immunol 2003 Jan;106(1):10-5

Department of Pathology, Stanford University School of Medicine, CA 94305, USA.

View Article

Download full-text PDF

Source
January 2003

In vivo manipulation of dendritic cells to induce therapeutic immunity.

Blood 2002 Mar;99(5):1676-82

Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.v99.5.1676DOI Listing
March 2002